TOULORGE, Damien,GUERREIRO DA SILVA, Serge,BRESSAC, Laurence
申请号：
AU2018308649
公开号：
AU2018308649A1
申请日:
2018.07.24
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention relates to a compound, which specifically binds to CD38, for use as a medicament in the prevention and/or treatment of a neurodegenerative disease and/or an inflammatory disease, by the opening of NAADP receptors Two Pore Channels TPC and/or TPC2, wherein said compound activates the opening of NAADP receptors Two Pore Channels TPC1 and/or TPC2.
